Capital International Investors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105M Buy
870,261
+9,526
+1% +$1.1M 0.02% 280
2025
Q4
$90.6M Sell
860,735
-2,532,633
-75% -$238M 0.01% 307
2025
Q3
$285M Sell
3,393,368
-671,607
-17% -$55.3M 0.05% 210
2025
Q2
$322M Sell
4,064,975
-748,830
-16% -$59.5M 0.06% 193
2025
Q1
$432M Sell
4,813,805
-1,466,945
-23% -$137M 0.09% 172
2024
Q4
$625M Sell
6,280,750
-24,396
-0.4% -$2.52M 0.12% 146
2024
Q3
$716M Buy
6,305,146
+73,176
+1% +$8.69M 0.14% 141
2024
Q2
$772M Buy
6,231,970
+208,117
+3% +$26.8M 0.16% 122
2024
Q1
$795M Buy
6,023,853
+5,865,948
+3,715% +$723M 0.16% 124
2023
Q4
$17.2M Buy
157,905
+4,069
+3% +$422K ﹤0.01% 384
2023
Q3
$16M Sell
153,836
-204,968
-57% -$22.1M ﹤0.01% 387
2023
Q2
$41.1M Buy
358,804
+3,743
+1% +$425K 0.01% 345
2023
Q1
$37.7M Sell
355,061
-609,954
-63% -$65.9M 0.01% 355
2022
Q4
$107M Buy
965,015
+3,725
+0.4% +$381K 0.03% 276
2022
Q3
$82.9M Buy
961,290
+2,324
+0.2% +$207K 0.02% 308
2022
Q2
$87.6M Sell
958,966
-911,533
-49% -$80.8M 0.02% 307
2022
Q1
$154M Sell
1,870,499
-15,017,143
-89% -$1.18B 0.04% 270
2021
Q4
$1.29B Sell
16,887,642
-6,037,697
-26% -$481M 0.27% 102
2021
Q3
$1.72B Sell
22,925,339
-5,990,137
-21% -$456M 0.39% 70
2021
Q2
$2.25B Sell
28,915,476
-5,856,571
-17% -$436M 0.51% 49
2021
Q1
$2.56B Sell
34,772,047
-1,541,832
-4% -$114M 0.65% 36
2020
Q4
$2.83B Sell
36,313,879
-3,734,237
-9% -$286M 0.77% 27
2020
Q3
$3.17B Buy
40,048,116
+2,271,388
+6% +$178M 0.98% 17
2020
Q2
$2.79B Buy
37,776,728
+8,569,354
+29% +$645M 0.91% 24
2020
Q1
$2.14B Sell
29,207,374
-12,322,892
-30% -$968M 0.88% 25
2019
Q4
$3.6B Buy
41,530,266
+1,084,452
+3% +$89.1M 1.22% 17
2019
Q3
$3.25B Buy
40,445,814
+1,739,119
+4% +$139M 1.24% 17
2019
Q2
$3.1B Buy
38,706,695
+1,300,446
+3% +$99.6M 1.24% 17
2019
Q1
$2.97B Buy
37,406,249
+2,594,396
+7% +$194M 1.28% 17
2018
Q4
$2.54B Buy
34,811,853
+243,986
+0.7% +$17.2M 1.27% 16
2018
Q3
$2.34B Buy
34,567,867
+22,142,025
+178% +$1.41B 1.07% 22
2018
Q2
$720M Buy
12,425,842
+353
+0% +$19.9K 0.81% 41
2018
Q1
$646M Buy
12,425,489
+658,354
+6% +$35.6M 0.75% 48
2017
Q4
$632M Buy
11,767,135
+1,681,831
+17% +$93.2M 0.71% 47
2017
Q3
$616M Buy
10,085,304
+3,592,963
+55% +$218M 0.74% 42
2017
Q2
$397M Buy
6,492,341
+2
+0% +$122 0.53% 65
2017
Q1
$394M Buy
6,492,339
+1,614,549
+33% +$98M 0.53% 60
2016
Q4
$274M Hold
4,877,790
0.4% 77
2016
Q3
$290M Hold
4,877,790
0.42% 76
2016
Q2
$268M Sell
4,877,790
-2,558,168
-34% -$136M 0.39% 77
2016
Q1
$375M Hold
7,435,958
0.58% 51
2015
Q4
$375M Sell
7,435,958
-135
-0% -$6.81K 0.58% 50
2015
Q3
$350M Sell
7,436,093
-4,594,297
-38% -$244M 0.64% 51
2015
Q2
$654M Sell
12,030,390
-7,192,943
-37% -$403M 1.11% 21
2015
Q1
$1.05B Buy
19,223,333
+1,608,680
+9% +$91.1M 1.92% 5
2014
Q4
$955M Buy
17,614,653
+3,392,916
+24% +$189M 1.95% 5
2014
Q3
$804M Buy
14,221,737
+2,691,295
+23% +$151M 1.96% 6
2014
Q2
$636M Buy
11,530,442
+200,535
+2% +$10.9M 1.64% 12
2014
Q1
$614M Buy
11,329,907
+419
+0% +$21.7K 1.65% 10
2013
Q4
$541M Buy
11,329,488
+3,277,295
+41% +$150M 1.68% 9
2013
Q3
$366M Buy
8,052,193
+2,091,075
+35% +$95.5M 1.56% 8
2013
Q2
$264M Buy
+5,961,118
New +$266M 1.2% 14

Other funds holding MRK

Capital International Investors's MRK Position: Q1 2026 in Review

Capital International Investors increased its Merck (MRK) stake by 1.1% in Q1 2026, buying an estimated $1.1M and bringing the position to 870,261 shares worth $105M. The position accounts for 0.02% of the portfolio, ranked #280.

Capital International Investors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.6B in Q4 2019. 3,782 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Capital International Investors held 870,261 shares of Merck worth $105M as of Q1 2026.
  • Capital International Investors bought 9,526 Merck shares in Q1 2026, an estimated $1.1M.
  • Merck made up 0.02% of Capital International Investors's portfolio in Q1 2026, its #280 holding.
  • Capital International Investors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Capital International Investors's Merck position peaked at $3.6B in Q4 2019.
  • 3,782 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.